Istituto di Ricerche Farmacologiche "Mario Negri"

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Italy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Kidney Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Case-Control Studies Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Odds Ratio Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

Research Output 1952 2018

ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells

Portale, F., Cricrì, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, F., Rizzari, C., Biondi, A., Dander, E. & D'Amico, G., Sep 27 2018, In : Haematologica.

Research output: Contribution to journalArticle

B-Lymphoid Precursor Cells
Leukemia
Bone Marrow
Aptitude
Mesenchymal Stromal Cells
5 Citations
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Maugeri Centre for Telehealth and Telecare (MCTT), 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle